Point72 Middle East Fze Opti Nose, Inc. Transaction History

Point72 Middle East Fze

  • $0
  • Q4 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$1.63 - $2.02 $20,745 - $25,708
12,727 New
12,727 $24,000

Others Institutions Holding OPTN

# of Institutions
2
Shares Held
5.29M
Call Options Held
0
Put Options Held
0
View Full List

About OptiNose, Inc.

OPTN Quotes by TradingView
  • Ticker OPTN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 83,277,504
  • Market Cap $487M
  • Description
  • OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...
More about OPTN
Track This Portfolio

Track Point72 Middle East Fze Portfolio

Follow Point72 Middle East Fze and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Middle East Fze with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email